Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2009
09/03/2009US20090221699 Fab I Inhibitors
09/03/2009US20090221646 Crystalline solvate of omeprazole sodium
09/03/2009US20090221641 Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists
09/03/2009US20090221639 Heterocyclic GPCR Agonists
09/03/2009US20090221616 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
09/03/2009US20090221611 Fused Triazole Tachykinin Receptor Antagonists
09/03/2009US20090221608 3-({4-[1-(2,2-difluoroethyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propanenitrile, used as serine/threonine protein kinase inhibitors, for the treatment of disease states associated with abnormal cell growth such as cancer
09/03/2009US20090221603 Heterocyclic amide derivatives as calcium channel blockers
09/03/2009US20090221602 Processes for preparing substituted pyrimidines
09/03/2009US20090221597 Heteroaryl derivatives as cftr modulators
09/03/2009US20090221591 Selective Inhibitors of Human Corticosteroid Synthases
09/03/2009US20090221587 Novel insecticides
09/03/2009US20090221583 such as 4-Benzenesulfinyl-N-{2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-benzamide, used for the treatment of syndrome X, obesity, insulin resistance, dyslipidemia and cardiovascular diseases
09/03/2009US20090221582 Piperazine Derivatives And Their Use In Therapy
09/03/2009US20090221580 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
09/03/2009US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
09/03/2009US20090221574 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
09/03/2009US20090221573 Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing
09/03/2009US20090221567 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
09/03/2009US20090221557 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009US20090221547 Immunosuppressant Compounds and Compositions
09/03/2009US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
09/03/2009US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound
09/03/2009US20090221424 Pesticides
09/03/2009US20090221423 Methods to Use 3-Pyridyl Derivatives as Pesticides
09/03/2009US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/03/2009US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides
09/03/2009CA2717011A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
09/03/2009CA2716898A1 Compound having 6-membered aromatic ring
09/03/2009CA2716855A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
09/03/2009CA2716747A1 Gamma secretase modulators for the treatment of alzheimer's disease
09/03/2009CA2716385A1 Carboxamide-heteroaryl derivatives for the treatment of diabetes
09/03/2009CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009CA2716256A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
09/03/2009CA2714573A1 Indazole derivatives
09/03/2009CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
09/02/2009EP2096144A1 Anthrapyridone compound, salt thereof, magenta ink composition containing the same, and colored body
09/02/2009EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same
09/02/2009EP2096107A1 Derivatives of squaric acid with anti-proliferative activity
09/02/2009EP2096104A1 Organic diamines as mGluR7 modulators
09/02/2009EP2094688A1 Heterocyclic compounds with cxcr3 antagonist activity
09/02/2009EP2094687A1 3 -amino- pyridine derivatives for the treatment of metabolic disorders
09/02/2009EP2094686A1 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl]ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc.
09/02/2009EP2094685A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
09/02/2009EP2094684A2 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators
09/02/2009EP2094683A2 Bicyclic compounds and use as antidiabetics
09/02/2009EP2094682A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
09/02/2009EP2094681A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
09/02/2009EP2094680A2 Imidazoles as aldosterone synthase inhibitors
09/02/2009EP2094671A1 Heterobicyclic metalloprotease inhibitors
09/02/2009EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
09/02/2009EP2094666A1 Cannabinoid receptor modulators
09/02/2009EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
09/02/2009EP2094656A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
09/02/2009EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives
09/02/2009EP2094644A2 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
09/02/2009EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase
09/02/2009EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation
09/02/2009EP1771440A4 Generic probes for the detection of phosphorylated sequences
09/02/2009EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof
09/02/2009EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/02/2009EP1458392B1 Acridones as inhibitors of impdh enzyme
09/02/2009EP1423115B9 Antiangiogenic activity of nitrogen substituted thalidomide analogs
09/02/2009EP1300395B1 4-substituted piperidine compound
09/02/2009EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors
09/02/2009CN101522662A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
09/02/2009CN101522661A Compounds and compositions as protein kinase inhibitors
09/02/2009CN101522660A Substituted pyrazinone derivatives for use as a medicine
09/02/2009CN101522659A Fungicide N-cycloalkyl-carboxamide, thiocarboxamide and N-substituted-carboximidamide derivatives
09/02/2009CN101519386A Large conductance calcium-activated K channel opener
09/02/2009CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof
09/02/2009CN100534990C Pyrrolidone carboxamides
09/01/2009US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
09/01/2009US7582765 Aryl aniline β2 adrenergic receptor agonists
09/01/2009US7582763 Enantioselective process
09/01/2009US7582761 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions
09/01/2009US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
09/01/2009US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring
09/01/2009US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582641 Gyrase inhibitors and uses thereof
09/01/2009US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders
09/01/2009US7582636 6-{4-[2 (4-tert-Butyl-phenyl)-imidazo[1,2-a]pyridin-5-yl]-piperazin-1-ylmethyl}- quinoxaline;oral delivery; bioavailability; luteinizing hormone releasing hormone) receptor antagonists; antifertility agents; hormone inhibitors
09/01/2009US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits
09/01/2009US7582634 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
09/01/2009US7582633 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/01/2009US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
09/01/2009US7582628 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/01/2009US7582627 3-aminoquinazolin-2,4-dione antibacterial agents
09/01/2009US7582625 -(4-Hydroxy-3,5-dimethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; headaches; non-insulin dependent diabetes; antidiabetic agents; cardiovascular/nervous system disorders; antiinflammatory agents
09/01/2009US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them
09/01/2009CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them
09/01/2009CA2467973C Pyridine derivatives as nmda receptor ligands
08/2009
08/27/2009WO2009105722A1 Compounds and compositions as modulators of gpr119 activity
08/27/2009WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor